Neurovertix is engineering a biomedical implant at the Motor Cortex — delivering targeted electro-stimulation to regenerate nerves, restore muscle function, and give spinal cord injury patients the chance to walk again.
Every person with a spinal cord injury deserves a path back to movement. That is not a dream — it is the technology we are building.
Uniting neuroscience, biomedical engineering, and AI to build a technology pipeline where none existed before.
Expertise spanning UK, USA and India — united by one purpose: restoring quality of life to patients worldwide.
Every engineering decision is measured against one question: does this help the patient who needs it most?
Our biomedical implant delivers precisely-calibrated electrical impulses at the Motor Cortex Area (MCA) — stimulating nerve regeneration and restoring the signalling pathways severed by spinal cord injury.
Unlike drug-based therapies or passive rehabilitation, we actively trigger the nervous system's own regenerative capacity — validated through over two decades of research and clinical outcomes.
Precision implant at the motor cortex delivering adaptive electrical signals to reignite dormant neural pathways below the injury site.
Developed with Oddstock Hospital (Salisbury District Hospital) — enabling fine-grained, multi-channel control over nerve and muscle activation sequences.
Non-invasive external neuro-transmission forming the foundation for techniques now used globally in spinal cord injury rehabilitation.
Machine learning continuously refines stimulation parameters to match each patient's unique neurophysiology — beyond one-size-fits-all protocols.
Research has demonstrated benefits beyond SCI — including a non-invasive Parkinson's treatment and complete elimination of pressure sores in paralysed patients.
A rigorous pre-clinical pipeline in a Rat model of SCI builds the validated evidence base required for human therapeutic trials.
From pioneering electro-stimulation research to globally unprecedented clinical outcomes — our journey is built on rigorous science and a relentless drive to help patients.
Formed a world beating team to begin researching the use of electrical transmissions in the field of Regenerative Medicine, specialising in spinal cord injuries. This research has been developed into a treatment using external neuro transmission of electrical impulses to regenerate nerves and/or muscles. Surface stimulation for spinal injuries developed that has led to the development of the recent spate of surface based electro stimulation techniques being presented. Advised and developed a 16 Channel Neural Stimulator with Oddstock Hospital (Salisbury District Hospital). Note: A 16 channel implant was recently used in the USA that enabled aided mobility during 2018..
World FirstInvited to conduct research in Cyprus in order to rehabilitate a paraplegic patient who had an operation to bypass spinal cord. This paraplegic patient needed surgery for a thoracic aortic aneurysm and a blood clot at the dorsal arch of the aorta. Through using the 16 channel stimulator and a course of electrical transmission to aid nerve regeneration, the patient’s muscle tone and pulse improved dramatically. Furthermore, the blood clot disappeared and the aneurysm reduced from 1.8 x 2.2mm to 1.5 x 1.0mm - results that are believed to be unprecedented anywhere in the world.
Globally UnprecedentedA non-invasive treatment for Parkinson’s disease that led to the withdrawal of drugs - Nerve and muscle regeneration in a patient with a fully-severed spinal cord - The disappearance of pressure sores in paralysed patients.
Non-invasive treatmentWe developed an implant with some of the best scientific minds in the world. Including neuro surgeons, neuro physiologists, Nano scientists and a world class team off engineers. Also developed the design and sourcing of a manufacturer for the implant device.
ImplantProf. Dallamore awarded dual PhDs in Neuroscience and Neuro Physics. Received the Albert Schweitzer Prize for Humanitarianism from the Congress of World Medicine, and the Knight Cross of Malta.
AwardCertificate of Excellence for fostering the Ideal of Humanitarianism, awarded by the First Lady of Sri Lanka. Appointed Knight Commander of the Knights of Charity.
AwardBuilt an association with a leading medical professional who is supporting our work namely, Professor Rajesh Kalaria; Professor of Cerebrovascular Pathology (Neuropathology), Director, Neurovascular Research Group (NRG), Institute of Neuroscience.
Neurovascular Research GroupAdvancing through animal model validation (Rat model of SCI) into a full therapeutic pipeline for human paraplegic patients — integrating AI with cutting-edge biomedical engineering at the Motor Cortex.
ActiveOur technology's novelty — two decades in the making — establishes real barriers to entry. Supported by experienced IP counsel in India and internationally, we protect our innovations today while enabling future expansion tomorrow.
Our unique stimulation protocols, device designs, and AI-driven methodologies form a proprietary technology stack that is powerful and genuinely difficult to replicate. We actively monitor the market for infringements and are prepared to enforce our rights.
Securing patents for our unique stimulation protocols, device architecture, and core technology — ensuring exclusivity and preventing unauthorised use by competitors.
Technology this unique creates significant competitive moats. Our expanding portfolio forms strong barriers against competitive threats and positions Neurovertix as a category leader.
Active market surveillance for potential infringements, supported by experienced IP attorneys in India and international counsel — ensuring no competitor builds on our work without authorisation.
Our IP framework grows with the technology — protecting future device generations, next-gen stimulator designs, and adjacent therapeutic applications as our pipeline evolves.
Incorporating AI into device design and adaptive stimulation protocols creates a proprietary technology stack that is both highly effective and uniquely difficult to replicate.
Our IP strategy is designed to scale — enabling us to bring this technology to patients, partners, and healthcare systems across every region of the world.
Three founders. Decades of experience across neuroscience, engineering, and entrepreneurial leadership — united by an unwavering belief that spinal cord injury does not have to be a life sentence.
We welcome conversations with engineers, researchers, investors, hospitals, and institutions who share our belief that spinal cord injury is a problem technology can solve.
Adoloratah Research & And Solutions Private Ltd - Mumbai, India & London, United Kingdom
adoloratahresearch@gmail.com
neurovertix.com